000 | 01999 a2200505 4500 | ||
---|---|---|---|
005 | 20250514205623.0 | ||
264 | 0 | _c20041221 | |
008 | 200412s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.48.11.4183-4188.2004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerg, Hans F | |
245 | 0 | 0 |
_aEmergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cNov 2004 |
||
300 |
_a4183-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 |
_aCarrier State _xmicrobiology |
650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
650 | 0 | 4 | _aCoronary Artery Bypass |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, Bacterial |
650 | 0 | 4 |
_aHaemophilus parainfluenzae _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacrolides _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNasal Cavity _xmicrobiology |
650 | 0 | 4 |
_aOropharynx _xmicrobiology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
700 | 1 | _aTjhie, Jeroen H T | |
700 | 1 | _aScheffer, Gert-Jan | |
700 | 1 | _aPeeters, Marcel F | |
700 | 1 | _avan Keulen, Peter H J | |
700 | 1 | _aKluytmans, Jan A J W | |
700 | 1 | _aStobberingh, Ellen E | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 11 _gp. 4183-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.11.4183-4188.2004 _zAvailable from publisher's website |
999 |
_c15193897 _d15193897 |